Drug Type Biological products |
Synonyms- |
Target |
Action antagonists |
Mechanism CD11a antagonists(Leukocyte adhesion glycoprotein LFA-1 alpha antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hematologic Diseases | Preclinical | - | - | |
| Hematologic Diseases | Preclinical | - | - | |
| HIV Infections | Preclinical | - | - | |
| HIV Infections | Preclinical | - | - | |
| Psoriasis | Preclinical | - | - | |
| Psoriasis | Preclinical | - | - |





